These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9017973)

  • 1. Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia.
    Ebstein RP; Macciardi F; Heresco-Levi U; Serretti A; Blaine D; Verga M; Nebamov L; Gur E; Belmaker RH; Avnon M; Lerer B
    Hum Hered; 1997; 47(1):6-16. PubMed ID: 9017973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia.
    Segman R; Neeman T; Heresco-Levy U; Finkel B; Karagichev L; Schlafman M; Dorevitch A; Yakir A; Lerner A; Shelevoy A; Lerer B
    Mol Psychiatry; 1999 May; 4(3):247-53. PubMed ID: 10395214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.
    Malhotra AK; Goldman D; Buchanan RW; Rooney W; Clifton A; Kosmidis MH; Breier A; Pickar D
    Mol Psychiatry; 1998 Jan; 3(1):72-5. PubMed ID: 9491816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study between schizophrenia and dopamine D3 receptor gene polymorphism.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trend for an association between schizophrenia and D3S1310, a marker in proximity to the dopamine D3 receptor gene.
    Jönsson EG; Nimgaonkar VL; Zhang XR; Shaw SH; Burgert E; Crocq MA; Chakravarti A; Sedvall GC
    Am J Med Genet; 1999 Aug; 88(4):352-7. PubMed ID: 10402502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood/early adolescence-onset and adult-onset schizophrenia. Heterogeneity at the dopamine D3 receptor gene.
    Maziade M; Martinez M; Rodrigue C; Gauthier B; Tremblay G; Fournier C; Bissonnette L; Simard C; Roy MA; Rouillard E; Mérette C
    Br J Psychiatry; 1997 Jan; 170():27-30. PubMed ID: 9068771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia.
    Hawi Z; McCabe U; Straub RE; O'Neill A; Kendler KS; Walsh D; Gill M
    Mol Psychiatry; 1998 Mar; 3(2):150-5. PubMed ID: 9577839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.
    Segman RH; Heresco-Levy U; Finkel B; Inbar R; Neeman T; Schlafman M; Dorevitch A; Yakir A; Lerner A; Goltser T; Shelevoy A; Lerer B
    Psychopharmacology (Berl); 2000 Nov; 152(4):408-13. PubMed ID: 11140333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
    Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
    Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
    Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.
    Rybakowski JK; Borkowska A; Czerski PM; Hauser J
    Mol Psychiatry; 2001 Nov; 6(6):718-24. PubMed ID: 11673801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of single nucleotide polymorphisms in the 5'-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia.
    Sivagnanasundaram S; Morris AG; Gaitonde EJ; McKenna PJ; Mollon JD; Hunt DM
    Neurosci Lett; 2000 Jan; 279(1):13-6. PubMed ID: 10670776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of dopamine D3 receptor gene and schizophrenia.
    Kennedy JL; Billett EA; Macciardi FM; Verga M; Parsons TJ; Meltzer HY; Lieberman J; Buchanan JA
    Am J Med Genet; 1995 Dec; 60(6):558-62. PubMed ID: 8825896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population.
    Kremer I; Rietschel M; Dobrusin M; Mujaheed M; Murad I; Blanaru M; Bannoura I; Müller DJ; Schulze TG; Reshef A; Gathas S; Schwab S; Wildenauer D; Bachner-Melman R; Belmaker RH; Maier W; Ebstein RP
    Am J Med Genet; 2000 Dec; 96(6):778-80. PubMed ID: 11121180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between schizophrenia and DRD3 or HTR2 receptor gene variants.
    Baritaki S; Rizos E; Zafiropoulos A; Soufla G; Katsafouros K; Gourvas V; Spandidos DA
    Eur J Hum Genet; 2004 Jul; 12(7):535-41. PubMed ID: 15083167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity at the dopamine D3 receptor gene in schizophrenic patients.
    Durany N; Thome J; Palomo A; Foley P; Riederer P; Cruz-Sánchez FF
    Neurosci Lett; 1996 Dec; 220(3):151-4. PubMed ID: 8994215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population.
    Staddon S; Arranz MJ; Mancama D; Perez-Nievas F; Arrizabalaga I; Anney R; Buckland P; Elkin A; Osborne S; Munro J; Mata I; Kerwin RW
    Schizophr Res; 2005 Feb; 73(1):49-54. PubMed ID: 15567076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients.
    Scharfetter J; Chaudhry HR; Hornik K; Fuchs K; Sieghart W; Kasper S; Aschauer HN
    Eur Neuropsychopharmacol; 1999 Dec; 10(1):17-20. PubMed ID: 10647091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.